Summary:

To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models.

Article written by Jacob Aptekar, Nicholas Donoghoe, Edd Fleming, Meredith Reichert, Erika Stanzl, and Kevin Webster

06|02|2019

Source:

McKensey

https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/precision-medicine-opening-the-aperture#

Pin It on Pinterest